US Stock MarketDetailed Quotes

BRSHW BRUUSH ORAL CARE INC C/WTS 03/08/2027 (TO PUR COM)

Watchlist
  • 0.008
  • 0.0000.00%
Close Mar 27 16:00 ET
0Market Cap0.00P/E (TTM)

BRUUSH ORAL CARE INC C/WTS 03/08/2027 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Apr 30, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
(Q2)Apr 30, 2022
(FY)Oct 31, 2021
(FY)Jan 31, 2021
(FY)Jan 31, 2020
Total revenue
7.80%325.53K
33.94%2.63M
789.68K
730.96K
301.98K
847.64%1.97M
334.50%901.16K
207.4K
Operating revenue
7.80%325.53K
33.94%2.63M
--789.68K
--730.96K
--301.98K
847.64%1.97M
334.50%901.16K
--207.4K
Cost of revenue
-18.90%79.34K
-15.93%822.38K
266.56K
166.84K
97.83K
1,368.92%978.24K
337.26%291.2K
66.6K
Gross profit
20.59%246.2K
83.35%1.81M
523.12K
564.11K
204.15K
601.10%987.2K
333.19%609.97K
140.81K
Operating expense
62.20%1.84M
138.88%12.15M
6.21M
1.69M
1.13M
238.54%5.09M
494.79%8.94M
1.5M
Selling and administrative expenses
65.65%1.82M
136.81%11.89M
--6.03M
--1.66M
--1.1M
236.99%5.02M
498.03%8.91M
--1.49M
-Selling and marketing expense
45.25%633.1K
156.06%7.25M
--4.24M
--411.52K
--435.86K
234.98%2.83M
217.12%2.68M
--845.62K
-General and administrative expense
79.07%1.19M
111.93%4.64M
--1.79M
--1.25M
--661.88K
239.64%2.19M
866.40%6.23M
--644.83K
Research and development costs
--1.5K
--96.43K
----
----
--0
--0
--0
----
Depreciation amortization depletion
-61.89%1.06K
179.16%15.35K
--6.84K
--2.87K
--2.79K
--5.5K
--0
----
-Depreciation and amortization
-61.89%1.06K
179.16%15.35K
--6.84K
--2.87K
--2.79K
--5.5K
--0
----
Other operating expenses
-50.49%15.77K
147.34%146.7K
--72.26K
--17.98K
--31.85K
380.90%59.31K
103.04%25.04K
--12.33K
Operating profit
-71.35%-1.59M
-152.25%-10.34M
-5.68M
-1.12M
-928.22K
-201.06%-4.1M
-511.49%-8.33M
-1.36M
Net non-operating interest income expense
88.30%-220.18K
-6,286.06%-3.84M
46.05K
-380.93K
-1.88M
-290.60%-60.18K
-17.67%-18.13K
-15.41K
Non-operating interest expense
-88.30%220.18K
6,286.06%3.84M
---46.05K
--380.93K
--1.88M
290.60%60.18K
17.67%18.13K
--15.41K
Other net income (expense)
1,648.83%1.34M
10,777.52%5.42M
5.01M
209.7K
76.37K
-3,328.09%-50.77K
-36,627.08%-543.93K
-1.48K
Gain on sale of security
1,610.63%1.31M
11,104.78%5.59M
--5.18M
--209.7K
--76.37K
-3,328.09%-50.77K
-36,627.08%-543.93K
---1.48K
Special income (charges)
---130.15K
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
--130.15K
----
----
----
--0
----
----
----
Other non- operating income (expenses)
--159.32K
---166.15K
----
----
----
----
----
----
Income before tax
82.62%-475.09K
-108.14%-8.77M
-625.95K
-1.29M
-2.73M
-205.42%-4.21M
-544.77%-8.89M
-1.38M
Income tax
Net income
82.62%-475.09K
-108.14%-8.77M
-625.95K
-1.29M
-2.73M
-205.42%-4.21M
-544.77%-8.89M
-1.38M
Net income continuous Operations
82.62%-475.09K
-108.14%-8.77M
---625.95K
---1.29M
---2.73M
-205.42%-4.21M
-544.77%-8.89M
---1.38M
Minority interest income
Net income attributable to the parent company
82.62%-475.09K
-108.14%-8.77M
-625.95K
-1.29M
-2.73M
-205.42%-4.21M
-544.77%-8.89M
-1.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
82.62%-475.09K
-108.14%-8.77M
-625.95K
-1.29M
-2.73M
-205.42%-4.21M
-544.77%-8.89M
-1.38M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Apr 30, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022(Q2)Apr 30, 2022(FY)Oct 31, 2021(FY)Jan 31, 2021(FY)Jan 31, 2020
Total revenue 7.80%325.53K33.94%2.63M789.68K730.96K301.98K847.64%1.97M334.50%901.16K207.4K
Operating revenue 7.80%325.53K33.94%2.63M--789.68K--730.96K--301.98K847.64%1.97M334.50%901.16K--207.4K
Cost of revenue -18.90%79.34K-15.93%822.38K266.56K166.84K97.83K1,368.92%978.24K337.26%291.2K66.6K
Gross profit 20.59%246.2K83.35%1.81M523.12K564.11K204.15K601.10%987.2K333.19%609.97K140.81K
Operating expense 62.20%1.84M138.88%12.15M6.21M1.69M1.13M238.54%5.09M494.79%8.94M1.5M
Selling and administrative expenses 65.65%1.82M136.81%11.89M--6.03M--1.66M--1.1M236.99%5.02M498.03%8.91M--1.49M
-Selling and marketing expense 45.25%633.1K156.06%7.25M--4.24M--411.52K--435.86K234.98%2.83M217.12%2.68M--845.62K
-General and administrative expense 79.07%1.19M111.93%4.64M--1.79M--1.25M--661.88K239.64%2.19M866.40%6.23M--644.83K
Research and development costs --1.5K--96.43K----------0--0--0----
Depreciation amortization depletion -61.89%1.06K179.16%15.35K--6.84K--2.87K--2.79K--5.5K--0----
-Depreciation and amortization -61.89%1.06K179.16%15.35K--6.84K--2.87K--2.79K--5.5K--0----
Other operating expenses -50.49%15.77K147.34%146.7K--72.26K--17.98K--31.85K380.90%59.31K103.04%25.04K--12.33K
Operating profit -71.35%-1.59M-152.25%-10.34M-5.68M-1.12M-928.22K-201.06%-4.1M-511.49%-8.33M-1.36M
Net non-operating interest income expense 88.30%-220.18K-6,286.06%-3.84M46.05K-380.93K-1.88M-290.60%-60.18K-17.67%-18.13K-15.41K
Non-operating interest expense -88.30%220.18K6,286.06%3.84M---46.05K--380.93K--1.88M290.60%60.18K17.67%18.13K--15.41K
Other net income (expense) 1,648.83%1.34M10,777.52%5.42M5.01M209.7K76.37K-3,328.09%-50.77K-36,627.08%-543.93K-1.48K
Gain on sale of security 1,610.63%1.31M11,104.78%5.59M--5.18M--209.7K--76.37K-3,328.09%-50.77K-36,627.08%-543.93K---1.48K
Special income (charges) ---130.15K--------------0------------
-Less:Impairment of capital assets --130.15K--------------0------------
Other non- operating income (expenses) --159.32K---166.15K------------------------
Income before tax 82.62%-475.09K-108.14%-8.77M-625.95K-1.29M-2.73M-205.42%-4.21M-544.77%-8.89M-1.38M
Income tax
Net income 82.62%-475.09K-108.14%-8.77M-625.95K-1.29M-2.73M-205.42%-4.21M-544.77%-8.89M-1.38M
Net income continuous Operations 82.62%-475.09K-108.14%-8.77M---625.95K---1.29M---2.73M-205.42%-4.21M-544.77%-8.89M---1.38M
Minority interest income
Net income attributable to the parent company 82.62%-475.09K-108.14%-8.77M-625.95K-1.29M-2.73M-205.42%-4.21M-544.77%-8.89M-1.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 82.62%-475.09K-108.14%-8.77M-625.95K-1.29M-2.73M-205.42%-4.21M-544.77%-8.89M-1.38M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg